These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15883924)
41. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Jhaveri M; Seal B; Pollack M; Wertz D Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740 [TBL] [Abstract][Full Text] [Related]
42. Diagnosis and management of insomnia in older people. McCall WV J Am Geriatr Soc; 2005 Jul; 53(7 Suppl):S272-7. PubMed ID: 15982376 [TBL] [Abstract][Full Text] [Related]
43. Clinical management of patients with insomnia. The role of zopiclone. Hajak G; Rodenbeck A Pharmacoeconomics; 1996; 10 Suppl 1():29-38. PubMed ID: 10163425 [TBL] [Abstract][Full Text] [Related]
44. Zopiclone, a third generation of hypnotics. Proceedings of a symposium of the 13th CINP (Collegium Internationale Neuropsychopharmacologicum) congress, Jerusalem, June 1982. Int Pharmacopsychiatry; 1982; 17 Suppl 2():1-250. PubMed ID: 7188367 [No Abstract] [Full Text] [Related]
45. Insomnia: an ignored health problem. Hamblin JE Prim Care; 2007 Sep; 34(3):659-74, viii. PubMed ID: 17868765 [TBL] [Abstract][Full Text] [Related]
46. Insomnia: evidence-based approaches to assessment and management. Morgan K; Kucharczyk E; Gregory P Clin Med (Lond); 2011 Jun; 11(3):278-81. PubMed ID: 21902086 [No Abstract] [Full Text] [Related]
47. Lunesta for the treatment of insomnia. Lajiness MJ Urol Nurs; 2008 Apr; 28(2):134-5. PubMed ID: 18488591 [No Abstract] [Full Text] [Related]
50. [Advantages and disadvantages of sleeping pills]. Kajaste S; Palomäki H Duodecim; 1991; 107(18):1501-8. PubMed ID: 1365383 [No Abstract] [Full Text] [Related]
51. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia. Snedecor SJ; Botteman MF; Bojke C; Schaefer K; Barry N; Pickard AS Sleep; 2009 Jun; 32(6):817-24. PubMed ID: 19544759 [TBL] [Abstract][Full Text] [Related]
52. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain. Goforth HW; Preud'homme XA; Krystal AD Sleep; 2014 Jun; 37(6):1053-60. PubMed ID: 24882900 [TBL] [Abstract][Full Text] [Related]
53. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with Zopiclone. Omvik S; Sivertsen B; Pallesen S; Bjorvatn B; Havik OE; Nordhus IH Behav Res Ther; 2008 May; 46(5):623-41. PubMed ID: 18417099 [TBL] [Abstract][Full Text] [Related]
54. Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo. Menza M; Dobkin RD; Marin H; Gara M; Bienfait K; Dicke A; Comella CL; Cantor C; Hyer L Mov Disord; 2010 Aug; 25(11):1708-14. PubMed ID: 20589875 [TBL] [Abstract][Full Text] [Related]
56. [The clinical evaluation of the action of Imovane on patients with insomnia]. Veĭn AM; Levin IaI; Eligulashvili TS; Posokhov SI; Kovrov GV; Bashmakov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):44-6. PubMed ID: 7975988 [No Abstract] [Full Text] [Related]
57. The art of prescribing. Risks and benefits of non-benzodiazepine receptor agonists in the treatment of acute primary insomnia in older adults. Antai-Otong D Perspect Psychiatr Care; 2006 Aug; 42(3):196-200. PubMed ID: 16916422 [No Abstract] [Full Text] [Related]
58. Consultation corner. Are the new sleep aids right for you? Neubauer D Johns Hopkins Med Lett Health After 50; 2006 Apr; 18(2):3, 5. PubMed ID: 16544431 [No Abstract] [Full Text] [Related]